These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66 related articles for article (PubMed ID: 1564977)
1. [Plasma concentrations of theophylline in patients with chronic obstructive pulmonary disease. What therapeutic limit should be used?]. Soto J; Sacristán JA Med Clin (Barc); 1992 Mar; 98(10):398-9. PubMed ID: 1564977 [No Abstract] [Full Text] [Related]
2. Theophylline binding to plasma proteins in patients with chronic obstructive pulmonary disease. Calandre EP; Pérez de la Cruz A; Alferez NP; Moreno Carretero E; Hinojosa R; Vázquez Mata G Int J Clin Pharmacol Res; 1986; 6(5):397-401. PubMed ID: 3781702 [TBL] [Abstract][Full Text] [Related]
3. Effect of theophylline on cortisol plasma concentrations in patients with chronic obstructive pulmonary disease. Gimeno F; Steenhuis EJ; Jonkman JH Int J Clin Pharmacol Ther Toxicol; 1990 Apr; 28(4):139-43. PubMed ID: 2187001 [TBL] [Abstract][Full Text] [Related]
4. Effect of various disease states on theophylline plasma levels and on pulmonary function in patients with chronic airway obstruction treated with a sustained release theophylline preparation. Dal Negro R; Turco P; Pomari C; Monici-Preti P Int J Clin Pharmacol Ther Toxicol; 1987 Jul; 25(7):401-5. PubMed ID: 3305382 [TBL] [Abstract][Full Text] [Related]
5. Serum theophylline concentrations and pulmonary function tests after administration of two sustained-release formulations containing theophylline in patients affected by chronic obstructive lung disease. Fontana G; Cresci F; Lo Sapio P; Panuccio P Int J Clin Pharmacol Res; 1987; 7(5):351-6. PubMed ID: 3667008 [TBL] [Abstract][Full Text] [Related]
6. [The evaluation in primary care of blood theophylline in patients with chronic obstructive pulmonary disease]. Isanta Pomar C; Subías Lorén P; Baquer Masgrau A; Auría Romeo C; Martín Moros JM; Izquierdo Clemente C Rev Clin Esp; 1991 Jun; 189(1):42-3. PubMed ID: 1924930 [No Abstract] [Full Text] [Related]
8. Miocamycin doesn't affect theophylline serum levels in COPD patients. Dal Negro R; Turco P; Pomari C; de Conti F Int J Clin Pharmacol Ther Toxicol; 1988 Jan; 26(1):27-9. PubMed ID: 3261281 [TBL] [Abstract][Full Text] [Related]
9. [The comparative efficacy of the prolonged-action theophylline preparations Theopek and Euphylong in elderly patients with chronic obstructive lung diseases]. Salikova VV; Nonikov VE; Belousov IuB Ter Arkh; 1993; 65(8):41-4. PubMed ID: 8211801 [TBL] [Abstract][Full Text] [Related]
10. [A single dose of theophylline in the evening in chronic obstructive airway disease. Serum concentration and lung function parameter]. Kaik G Fortschr Med; 1984 Nov; 102(43):1120-2. PubMed ID: 6510864 [TBL] [Abstract][Full Text] [Related]
11. [Determination of the serum level of theophylline in a group of patients with chronic obstructive bronchopneumopathy]. Marzo C; Gnasso P; Dericoloso A; Borrelli G; Vacca C; Cantone F Arch Monaldi; 1981; 36(1-2):71-5. PubMed ID: 7348162 [No Abstract] [Full Text] [Related]
12. [Levels of blood theophylline in patients with acute bronchospasm]. Martínez MJ; Martínez B; Saucedo R; García Delgado R; García Morillas M; Puche E Rev Clin Esp; 1989 May; 184(9):470-2. PubMed ID: 2772324 [TBL] [Abstract][Full Text] [Related]
13. [Hemodynamics of pulmonary circulation in patients with chronic obstructive lung disease and pulmonary hypertension as dependent on the theophylline concentration of the serum]. Grützmacher I; Schicht R; Schlaeger R; Sill V Prax Klin Pneumol; 1984 Jan; 38(1):19-25. PubMed ID: 6709589 [No Abstract] [Full Text] [Related]
14. Post-mortem concentrations of salbutamol, terbutaline and theophylline in asthma patients. Lindsjö M; Boman G; Lindström B; Strandberg K; Wiholm BE Eur J Respir Dis; 1987 Jul; 71(1):2-9. PubMed ID: 3653302 [TBL] [Abstract][Full Text] [Related]
15. [Norfloxacin does not raise theophylline concentrations in plasma]. Tamura G; Satoh K; Ohtsu H; Fujimoto Y; Aizawa T; Sakai K; Mue S; Takishima T Arerugi; 1987 May; 36(5):262-7. PubMed ID: 3662833 [No Abstract] [Full Text] [Related]
16. Which of the following statements about the use of specific therapies in the treatment of chronic obstructive pulmonary disease are true? Can Fam Physician; 1993 Nov; 39():2318, 2322. PubMed ID: 7903571 [No Abstract] [Full Text] [Related]
17. The combined effect of theophylline and terbutaline in patients with chronic obstructive airway diseases. Lamont H; van der Straeten M; Pauwels R; Moerman E; Bogaert M Eur J Respir Dis; 1982 Jan; 63(1):13-22. PubMed ID: 7040097 [TBL] [Abstract][Full Text] [Related]
18. The disposition of theophylline in blood in chronic obstructive lung disease. Ebden P; Banks J; Peel T; Buss DC; Routledge PA; Spragg BP Ther Drug Monit; 1986; 8(4):424-6. PubMed ID: 3824427 [TBL] [Abstract][Full Text] [Related]
19. Effect of theophylline in chronic obstructive lung disease. Umut S; Gemicioğlu B; Yildirim N; Barlas A; Ozüner Z Int J Clin Pharmacol Ther Toxicol; 1992 May; 30(5):149-52. PubMed ID: 1592541 [TBL] [Abstract][Full Text] [Related]
20. Home monitoring of theophylline levels: a novel therapeutic approach. Chandler MH; Clifton GD; Louis BA; Coons SJ; Foster TS; Phillips BA Pharmacotherapy; 1990; 10(4):294-300. PubMed ID: 2388876 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]